TF and Alzheimer disease: To determine the effect of Tf-MeLioNs treatment on AD progression, Tf-MeLioNs, LioNs, or vehicle (control) were administered via the tail vein (2.5 mg/kg; one injection every week) to male 5XFAD AD transgenic mice aged 24 to 29 weeks.